SOW
KRYS icon

State of Wyoming’s Krystal Biotech KRYS Stock Holding History

State of Wyoming’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
+4,767
New +$1.42M 0.18% 50
2022
Q3 		– Sell
-69
Closed -$5K – 1735
2022
Q2 		$5K Sell
69
-688
-91% -$42.8K ﹤0.01% 1721
2022
Q1 		$50K Buy
757
+244
+48% +$15.2K 0.03% 1056
2021
Q4 		$36K Buy
513
+74
+17% +$4.31K 0.02% 1257
2021
Q3 		$23K Sell
439
-256
-37% -$15.2K 0.01% 915
2021
Q2 		$47K Buy
695
+465
+202% +$32.5K 0.03% 763
2021
Q1 		$18K Buy
+230
New +$16.7K 0.03% 330

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State of Wyoming's KRYS Position: Q2 2026 in Review

State of Wyoming opened a new position in Krystal Biotech (KRYS) in Q2 2026: 4,767 shares worth $1.77M. The stake represents 0.18% of the portfolio and ranks #50 among its holdings. This is a return to the name: State of Wyoming previously reported a position in KRYS as recently as Q2 2022.

State of Wyoming first reported a position in KRYS in Q1 2021 and has held it in 7 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • State of Wyoming held 4,767 shares of Krystal Biotech worth $1.77M as of Q2 2026.
  • Krystal Biotech was a new State of Wyoming position in Q2 2026.
  • Krystal Biotech made up 0.18% of State of Wyoming's portfolio in Q2 2026, its #50 holding.
  • State of Wyoming first reported a position in Krystal Biotech in Q1 2021 and has held it in 7 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.